ForteBio Adds Marketing and Sales Executive -- ForteBio Preparing for Product Sale

Aug 22, 2015

MENLO PARK, Calif. — August 22, 2005 — ForteBio, Inc., a life sciences company providing tools for the detection and analysis of biomolecules and their interactions, today announced the addition of Stephen Oldfield, Ph.D., to the new position of Vice President, Marketing and Sales. Dr. Oldfield joined the company in early August from Molecular Devices Corporation, where he was Vice President, Worldwide Marketing. He will report to Winnie H. Wan, Ph.D., President & Chief Executive Officer of ForteBio, and will be responsible for recruiting both marketing and sales personnel in preparation for the company’s first product launch later this year.

“I am delighted to have a marketing and sales executive with the highly relevant expertise that Stephen brings to ForteBio,” stated Dr. Wan. “We welcome his leadership as we develop our marketing strategy and put our sales force in place in anticipation of the launch of our first product later this year. Stephen has a broad and deep skill set — a combination of technical knowledge of the life sciences industry and a proven record in successful marketing and sales of consumable and reagent-driven systems, high level strategic planning, and developing and managing international marketing and sales distribution channels.”

Dr. Oldfield has been working in the commercial life sciences business for more than 20 years. Prior to his six years at Molecular Devices, he held senior marketing executive positions at Molecular Probes (now Invitrogen Detection Systems), FMC BioProducts (now part of Cambrex Corporation), Molecular Dynamics (now part of GE Medical Systems) and Pharmacia Biotechnology AB (now part of GE Healthcare). Dr. Oldfield received his Ph.D. in Pure & Applied Biology from the Imperial College, London and his B.Sc. in Genetics from the University of Sheffield in the United Kingdom.

About ForteBio, Inc. ForteBio is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification and characterization of proteinprotein interaction. These systems enable real-time analysis of biomolecular interactions in micro-volume sample sizes, providing information on affinity, kinetics and concentration. Most importantly, ForteBio's analytical capabilities provide greater value in applications where existing methods have limitations in throughput, performance and cost. The company is located in Menlo Park, California. For more information, please visit www.fortebio.com.

Contact Information :
Winnie H. Wan, Ph.D.
Chief Executive Officer
650 322-1360 ext 111
wwan@fortebio.com